Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.
作者： Rachel G. Greenberg , Sreepriya Gayam , Destiny Savage , Andrew Tong , Daniel Gorham
DOI: 10.1016/J.JPEDS.2018.11.043
关键词: Pediatrics 、 Incidence (epidemiology) 、 Furosemide 、 Retrospective cohort study 、 Birth weight 、 Gestational age 、 Postmenstrual Age 、 Medicine 、 Diuretic 、 Bronchopulmonary dysplasia
摘要: … 7 and 36 weeks PMA and the median percentage of days … of exposure was 4 days (2-10), 22% of exposed infants had a duration of 1 day, 23% of infants had a duration of ≥14 days, …
sci-hub.se 参考文章(41)
Michael Baiocchi, Jing Cheng, Dylan S. Small, Instrumental variable methods for causal inference Statistics in Medicine. ,vol. 33, pp. 2297- 2340 ,(2014) , 10.1002/SIM.6128
Barbara J Stoll, Nellie I Hansen, Edward F Bell, Michele C Walsh, Waldemar A Carlo, Seetha Shankaran, Abbot R Laptook, Pablo J Sánchez, Krisa P Van Meurs, Myra Wyckoff, Abhik Das, Ellen C Hale, M Bethany Ball, Nancy S Newman, Kurt Schibler, Brenda B Poindexter, Kathleen A Kennedy, C Michael Cotten, Kristi L Watterberg, Carl T D’Angio, Sara B DeMauro, William E Truog, Uday Devaskar, Rosemary D Higgins, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, None, Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012 JAMA. ,vol. 314, pp. 1039- 1051 ,(2015) , 10.1001/JAMA.2015.10244
Henry L Halliday, Richard A Ehrenkranz, Lex W Doyle, Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews. ,(2014) , 10.1002/14651858.CD001146.PUB2
S de Denus, J L Rouleau, D L Mann, G S Huggins, T P Cappola, S H Shah, J Keleti, Y F Zada, S Provost, A Bardhadi, M S Phillips, V Normand, I Mongrain, M-P Dubé, A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials Pharmacogenomics Journal. ,vol. 17, pp. 192- 200 ,(2017) , 10.1038/TPJ.2016.4
Aisling Gough, Dale Spence, Mark Linden, Henry L. Halliday, Lorcan P.A. McGarvey, General and Respiratory Health Outcomes in Adult Survivors of Bronchopulmonary Dysplasia: A Systematic Review Chest. ,vol. 141, pp. 1554- 1567 ,(2012) , 10.1378/CHEST.11-1306
Eduardo Bancalari, Nelson Claure, Ilene R.S Sosenko, Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition Seminars in Neonatology. ,vol. 8, pp. 63- 71 ,(2003) , 10.1016/S1084-2756(02)00192-6
John P. Mitchell, Dan Schuller, Frank S. Calandrino, Daniel P. Schuster, Improved Outcome Based on Fluid Management in Critically III Patients Requiring Pulmonary Artery Catheterization American Review of Respiratory Disease. ,vol. 145, pp. 990- 998 ,(1992) , 10.1164/AJRCCM/145.5.990
Patricia Y. Chu, Kevin D. Hill, Reese H. Clark, P. Brian Smith, Christoph P. Hornik, Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database Early Human Development. ,vol. 91, pp. 345- 350 ,(2015) , 10.1016/J.EARLHUMDEV.2015.04.001
Matthew M Laughon, John C Langer, Carl L Bose, P Brian Smith, Namasivayam Ambalavanan, Kathleen A Kennedy, Barbara J Stoll, Susie Buchter, Abbot R Laptook, Richard A Ehrenkranz, C Michael Cotten, Deanne E Wilson-Costello, Seetha Shankaran, Krisa P Van Meurs, Alexis S Davis, Marie G Gantz, Neil N Finer, Bradley A Yoder, Roger G Faix, Waldemar A Carlo, Kurt R Schibler, Nancy S Newman, Wade Rich, Abhik Das, Rosemary D Higgins, Michele C Walsh, None, Prediction of Bronchopulmonary Dysplasia by Postnatal Age in Extremely Premature Infants American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 1715- 1722 ,(2011) , 10.1164/RCCM.201101-0055OC
S V Vormfelde, D Sehrt, M R Toliat, M Schirmer, I Meineke, M Tzvetkov, P Nürnberg, J Brockmöller, Genetic Variation in the Renal Sodium Transporters NKCC2, NCC, and ENaC in Relation to the Effects of Loop Diuretic Drugs Clinical Pharmacology & Therapeutics. ,vol. 82, pp. 300- 309 ,(2007) , 10.1038/SJ.CLPT.6100131